Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Neutrophil Gelatinase Associated Lipocalin in Early Detection of Acute Kidney Injury and Prediction of Patient Outcome in Critically Ill Patients; a Prospective, Observational, Non-randomized Study

NCT06691607 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT06691607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06691607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Neutrophil Gelatinase Associated Lipocalin in Early Detection of Acute Kidney Injury and Prediction of Patient Outcome in Critically Ill Patients; a Prospective, Observational, Non-randomized Study
Lead sponsor
Sohag University
Phase
Observational
Overall status
Completed
Start date
April 1, 2020
Completion date
June 1, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to determine if blood level (ngal) could accurately early detect acute renal damage in all patients requiring critical care